Latest news

Filters
May 8, 2018

FDA Grants Fast Track designation to Debiopharm International’s Debio 1347 for the treatment of patients with unresectable or metastatic tumors…

Read more
April 5, 2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

Read more
March 22, 2018

Challenge Qualité de vie du patient 2018 : l’appel à projets est ouvert !

Read more
February 19, 2018

GenePOC launches its revogene™ instrument and GBS LB test in Canada

Read more
February 15, 2018

Debiopharm continues the fight against antibiotic resistance with investment in ABAC Therapeutics Inc.

Read more
February 7, 2018

Le groupe autrichien ams acquiert KeyLemon

Read more
December 13, 2017

Debiopharm et la HES-SO Valais-Wallis célèbrent 20 ans de partenariat public-privé en collaborant au développement d’une nouvelle technologie de marquage…

Read more
November 28, 2017

GenePOC Launches its GenePOC™ CDiff test in the United States

Read more
November 22, 2017

Debiopharm International SA Launches Clinical Trials Website for Patients: patients.debiopharm.com

Read more